143.3 million Brazilians completed vaccination

143.3 million Brazilians completed vaccination
143.3 million Brazilians completed vaccination

Brazil ends 2021 with more than 143.3 million inhabitants with complete vaccination against covid-19. In all, 143,356,785 Brazilians took the second dose or the single dose of the immunizing agent against the disease, equivalent to 67.2% of the national population. The information comes from the consortium of press vehicles from which the UOL is part, based on data provided by the state health departments.

The year of vaccination in the country ends amid a period of uncertain numbers. For at least three weeks, several states have struggled to update their case, death and vaccination data. The problem has occurred since the hacker invasion of the Ministry of Health website, the application and the ConnectSUS page (a platform that shows proof of vaccination against covid-19), on the last 10th.

Without these updates, the analysis of the progress of vaccination in Brazil is compromised, as well as the monitoring of the average number of cases and deaths caused by the disease. This happens amid the daily growth of new cases of covid-19 in the world, caused by the advance of the omicron variant.

With data registered from only ten states, 38,460 Brazilians completed the vaccination cycle in the last 24 hours – of these, 37,574 took the second dose and another 886, the only one. In this same interval, 9,618 people received the first and 61,465 the booster, totaling 109,543 doses of immunizing administered between yesterday and today throughout the national territory.

In all, 161,221,915 inhabitants were vaccinated with the first dose, which represents 75.58% of the country’s population. The number of booster doses applied so far has reached 26,311,179.

Among the federation units, the state of São Paulo remains in the lead among those with the largest portion of its population with complete vaccination: 78.48% of its inhabitants. Next, appear Piauí (74.04%), Mato Grosso do Sul (72.07%), Minas Gerais (71.68%) and Rio Grande do Sul (69.74%).

Piauí occupies the first position, proportionally, regarding the application of the first dose: 82.99% of the local population. São Paulo (82.08%), Santa Catarina (78.72%), Paraná (77.85%) and Rio Grande do Sul (77.66%) come next.

With unstable data, Brazil does not know if omicron advances in the country

Science has already indicated in recent studies that the omicron variant of covid-19 should be more transmissible — that is, it infects other people more easily — than other strains. In recent days, amidst the holiday season, the variant caused a surge in new cases in the US and the UK.

But, here in Brazil, it is not possible to know if the variant has caused a jump in infections, nor can it be possible to draw a reliable scenario of the virus’ behavior in the country. With systems down and data out of date, the mapping of the disease that killed more than 600 thousand people in Brazil is outdated.

Instability in the Ministry of Health’s systems is not a new problem and has not yet been properly corrected. In September, UOL reported this underreporting while the federal government’s portfolio claimed changes in the system to “better respond to surveillance actions”.

Vehicles unite for information

In response to the Jair Bolsonaro government’s decision to restrict access to data on the covid-19 pandemic, the media UOL, O Estado de S. Paulo, Folha de S.Paulo, O Globo, g1 and Extra formed a consortium to work collaboratively to seek the necessary information directly from the state health secretariats of the 27 units of the Federation.

The federal government, through the Ministry of Health, should be the natural source of these numbers, but the attitudes of authorities and the president himself during the pandemic cast doubt on the availability of the data and its accuracy.

For Latest Updates Follow us on Google News

PREV On TV, Bolsonaro criticizes vaccination passport, distorts and omits information | Politics
NEXT Omicron is less aggressive because it mainly avoids attacking the lungs